Shandong Jiacheng Pharmaceutical Technology Co., Ltd. was established in October 2019 with a total investment of 350 million yuan. The factory was successfully established in May 2020 in the provincial-level chemical industry park of Dingtao District, Heze, Shandong, covering an area of more than 70,000 square meters with a construction area of 50,000 square meters. It includes production workshops for pharmaceutical intermediates, APIs (Active Pharmaceutical Ingredients), new polymer materials, as well as supporting facilities for environmental protection, safety, testing, R&D (Research and Development), office space, and storage. The company has more than 200 employees and boasts excellent production capacity and comprehensive processes. There are currently two main product lines: pharmaceutical intermediates and material chemicals. Seven pharmaceutical intermediates and six new polymer material additives are now in production, with an annual production capacity of 1,000 tons of pharmaceutical intermediates and 11,000 tons of polymer material additives. The current pharmaceutical intermediate products of the company include: D-Cysteine Hydrochloride, Epinastine Hydrochloride, Methylparaben, Sodium Tartrate Tetrahydrate, Butylphthalide, Ambroxol, and Methylthiotetrazole.
Year of Establishment:
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
Other Competitive Advantages:
Patents and Copyrights:
Audited Supplier
Pharma Sources Insight January 2025
